Diagnosis, treatment and monitoring of diabetic eye control (Q35981628)

11 August 2017

title

Diagnosis, treatment and monitoring of diabetic eye control (English)

1 reference

11 August 2017

Stephan Radda

1

1 reference

11 August 2017

Matthias Bolz

2

1 reference

11 August 2017

Stefan Egger

3

1 reference

11 August 2017

Vanessa Gasser-Steiner

4

1 reference

11 August 2017

Martina Kralinger

5

1 reference

11 August 2017

Stefan Mennel

6

1 reference

11 August 2017

Christoph Scholda

7

1 reference

11 August 2017

Ulrike Stolba

8

1 reference

11 August 2017

Andreas Wedrich

9

1 reference

11 August 2017

Katharina Krepler

10

1 reference

11 August 2017

language of work or name

German

0 references

publication date

6 April 2016

1 reference

11 August 2017

published in

Vienna Clinical Weekly

1 reference

11 August 2017

volume

128 Suppl 2

1 reference

11 August 2017

page(s)

S97-102

1 reference

Practice patterns in diabetic retinopathy: part 1: analysis of retinopathy follow-up

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Revisiting Diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Epidemiology of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Optical coherence tomography in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Precision and reliability of retinal thickness measurements in foveal and extrafoveal areas of healthy and diabetic eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

A systematic correlation of angiography and high-resolution optical coherence tomography in diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Quality assurance in screening for sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

The pathogenesis of edema in diabetic maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Lowering the risk of visual impairment and blindness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Intravitreal aflibercept for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Vitrectomy in diabetic patients with a blind fellow eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Prevention of blindness in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00508-016-0983-Z

Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications

21 January 2018

1 reference

12 December 2020

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Effect of cataract surgery on the progression of diabetic retinopathy

1 reference

12 December 2020

Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group

1 reference

12 December 2020

A diabetic retinopathy screening program as a strategy for blindness prevention

1 reference

12 December 2020

Causes of vitreous hemorrhage.

1 reference

12 December 2020

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial

1 reference

12 December 2020

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10

1 reference

12 December 2020

Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. The Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18

1 reference

12 December 2020

United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus

1 reference

12 December 2020

Case reports to accompany Early Treatment Diabetic Retinopathy Study Reports 3 and 4. The Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

The relationship of puberty to diabetic retinopathy

1 reference

12 December 2020

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Early photocoagulation in patients with either type I or type II diabetes

1 reference

12 December 2020

Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

10.1007/S00508-016-0983-Z

Identifiers

DOI

1 reference

11 August 2017

1 reference